Data is not available at this time.
eWeLL Co., Ltd. operates in the Japanese healthcare technology sector, specializing in cloud-based business support solutions for visiting nursing stations. The company’s flagship product, iBow, is a SaaS platform designed to enhance operational efficiency for nursing care providers, integrating functions like insurance claim processing, attendance tracking, and care claim transmission. By addressing critical administrative pain points in Japan’s aging-care industry, eWeLL has carved a niche in a high-demand market. The company’s focus on digitizing workflows for nursing stations positions it as a key enabler in Japan’s rapidly expanding healthcare infrastructure. With no direct debt and a scalable SaaS model, eWeLL benefits from recurring revenue streams and low capital intensity, reinforcing its competitive edge in a regulatory-heavy sector. Its market position is further strengthened by Japan’s demographic trends, where demand for elderly care services continues to rise, driving adoption of efficiency-focused solutions like iBow.
In FY 2024, eWeLL reported revenue of JPY 2.57 billion, with net income reaching JPY 808 million, reflecting a robust net margin of approximately 31.4%. Operating cash flow stood at JPY 857 million, underscoring efficient cash conversion. Minimal capital expenditures (JPY -17.7 million) highlight the asset-light nature of its SaaS model, allowing high returns on invested capital.
The company’s diluted EPS of JPY 53.02 demonstrates strong earnings power, supported by a debt-free balance sheet. With zero total debt and JPY 1.97 billion in cash, eWeLL maintains exceptional capital efficiency, reinvesting cash flows into growth initiatives without leverage constraints.
eWeLL’s balance sheet is notably healthy, with JPY 1.97 billion in cash and equivalents and no debt. This pristine financial position provides flexibility for strategic investments or acquisitions, while its positive operating cash flow (JPY 857 million) ensures sustainable liquidity.
The company’s growth is tied to Japan’s expanding elderly care sector, with SaaS adoption driving recurring revenue. A dividend of JPY 12 per share indicates a shareholder-friendly policy, though the payout ratio remains conservative, prioritizing reinvestment for scalable expansion.
At a market cap of JPY 36.7 billion, eWeLL trades at a premium, reflecting investor confidence in its niche market leadership and SaaS-driven margins. A beta of 1.201 suggests moderate volatility, aligned with growth-oriented tech peers.
eWeLL’s strategic focus on digitizing nursing care administration aligns with Japan’s demographic needs, offering long-term tailwinds. Its debt-free model and high profitability position it well for organic growth or strategic partnerships, though competition in healthcare SaaS could intensify.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |